A promising approach of GD2-specific chimeric antigen receptor (CAR) T cells with CD28/4.1BB costimulatory domains for treatment of GD2+sarcomas

被引：0
|
作者：
De Angelis, B. [1 ]
Camera, A. [1 ]
Orlando, D. [1 ]
Guercio, M. [1 ]
Sinibaldi, M. [1 ]
Cembrola, B. M. [1 ]
Caruso, S. [1 ]
Abbaszadeh, Z. [1 ]
Bovetti, K. [1 ]
Milano, G. M. [1 ]
Russo, I. [1 ]
De Vito, R. [1 ]
Quintarelli, C. [1 ]
Locatelli, F. [1 ]
机构：
[1] Osped Pediat Bambino Gesu, Rome, Italy
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P170
引用
收藏
页码：A69 / A70
页数：2
相关论文
共 44 条
  • [21] CD28 DELIVERS A COSTIMULATORY SIGNAL INVOLVED IN ANTIGEN-SPECIFIC IL-2 PRODUCTION BY HUMAN T-CELLS
    NORTON, SD
    URDAHL, KB
    ZUCKERMAN, L
    SHEFNER, R
    MILLER, J
    JENKINS, MK
    FASEB JOURNAL, 1992, 6 (04): : A1224 - A1224
  • [22] NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma
    Xu, Xin
    Huang, Wei
    Heczey, Andras
    Liu, Daofeng
    Guo, Linjie
    Wood, Michael
    Jin, Jingling
    Courtney, Amy N.
    Liu, Bin
    Di Pierro, Erica J.
    Hicks, John
    Barragan, Gabriel A.
    Ngai, Ho
    Chen, Yuhui
    Savoldo, Barbara
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7126 - 7138
  • [23] Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
    Jiayi Yu
    Xiaowen Wu
    Junya Yan
    Huan Yu
    Longwen Xu
    Zhihong Chi
    Xinan Sheng
    Lu Si
    Chuanliang Cui
    Jie Dai
    Meng Ma
    Tianxiao Xu
    Yan Kong
    Jun Guo
    Journal of Hematology & Oncology, 11
  • [24] Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
    Yu, Jiayi
    Wu, Xiaowen
    Yan, Junya
    Yu, Huan
    Xu, Longwen
    Chi, Zhihong
    Sheng, Xinan
    Si, Lu
    Cui, Chuanliang
    Dai, Jie
    Ma, Meng
    Xu, Tianxiao
    Kong, Yan
    Guo, Jun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [25] A folate receptor alpha specific, CD28/CD40-based chimeric costimulatory antigen receptor (CoStAR™), enhances anti-tumour activity of T cells and tumour infiltrating lymphocytes
    Kalaitsidou, Milena
    Moon, Owen
    Bao, Leyuan
    Dudley, Mark
    Hawkins, Robert
    Kueberuwa, Gray
    Bridgeman, John Stephen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 467 - 467
  • [26] Direct Comparison of Anti-CD33 and Anti-CD123 Chimeric Antigen Receptor T Cells with CD28 or 41BB Co-Stimulatory Domains for Treatment of Acute Myeloid Leukemia
    Tarun, Samiksha
    Qin, Haiying
    Yang, Lila
    Chien, Christopher Daniel
    Kohler, Mark Eric
    Fry, Terry J.
    BLOOD, 2017, 130
  • [27] NKT Cells Co-Expressing a GD2-Specific Chimeric Antigen Receptor and IL-15 Show Enhancedin Vivopersistence and Antitumor Activity Against Neuroblastoma
    Xu, Xin
    Huang, Wei
    Heczey, Andras
    Liu, Daofeng
    Guo, Linjie
    Wood, Micheal
    Jin, Jinglin
    Courtney, Amy
    Liu, Bin
    DiPiero, Erica
    Hicks, John
    Barragan, Gabriel
    Savoldo, Barbara
    Dotti, Gianpietro
    Metelitsa, Leonid
    MOLECULAR THERAPY, 2019, 27 (04) : 174 - 174
  • [28] NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
    Teng, Xia
    Li, Shance
    Zhang, Chaoting
    Ding, Huirong
    Tian, Zhihua
    Zhu, Yuge
    Liu, Ting
    Zhang, Guanyu
    Sun, Kang
    Xie, Huimin
    Tu, Jiaxin
    Lu, Zheming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [29] Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
    Kailayangiri, Sareetha
    Altvater, Bianca
    Spurny, Christian
    Jamitzky, Silke
    Schelhaas, Sonja
    Jacobs, Andreas H.
    Wiek, Constanze
    Roellecke, Katharina
    Hanenberg, Helmut
    Hartmann, Wolfgang
    Wiendl, Heinz
    Pankratz, Susann
    Meltzer, Jutta
    Farwick, Nicole
    Greune, Lea
    Fluegge, Maike
    Rossig, Claudia
    ONCOIMMUNOLOGY, 2017, 6 (01):
  • [30] Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors
    Zhao, W.
    Dong, L.
    Wang, H.
    Zheng, X.
    Zhang, C.
    Wang, K.
    Zhu, G.
    Wang, B.
    Qin, M.
    Liu, Y.
    Zhang, D.
    Jin, M.
    Zheng, H.
    Zhang, L.
    Ma, X.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S38 - S38
12345